Light Therapy in End Stage Kidney Disease (NCT06310161)
Bright Light Therapy to Treat Fatigue in End Stage Kidney Disease
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis. The main aim is to determine if light therapy decreases fatigue severity. Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (4 items).
Location: University of Pennsylvania — Philadelphia, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria
- Eye disorders: cataracts, glaucoma, retinal disorders (e.g. macular degeneration)
- Participants with photosensitivity (e.g. epilepsy)
- Hospitalized or acutely ill
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- University of Pennsylvania — Philadelphia, Pennsylvania
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
- 💵 Compensation indicated: Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment.
More studies in End Stage Renal Disease
- PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis — Washington D.C., District of Columbia
- Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients — Dallas, Texas
- An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL — Winnipeg, Manitoba
- The Effect of a Prehabilitation Exercise Program on Physical Functioning for Patients Undergoing Kidney Transplantation — Vancouver, British Columbia
- Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis — Boston, Massachusetts
Explore by condition: All End Stage Renal Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.